Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
Cloudy. Medium chance of showers, becoming less likely late this afternoon and evening. Winds southwesterly 20 to 30 km/h turning southerly 25 to 40 km/h in the middle of the day then decreasing to 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results